References
1 Present address: 6-14-44, Asabu-cho,
Kita-ku, Sapporo
001-0045, Japan, Fax: +81(11)7476963,
E-mail:
amurai@rmail.plala.or.jp
For the isolation and structure
determination of ciguatoxin, see:
2a
Scheuer PJ.
Takahashi W.
Tsutsumi J.
Yoshida T.
Science
1967,
155:
1267
2b
Tachibana K.
Ph.D.
Thesis
University of Hawaii;
Hawaii:
1980.
2c
Nukina M.
Koyanagi LM.
Scheuer PJ.
Toxicon
1984,
22:
169
2d
Murata M.
Legrand A.-M.
Ishibashi Y.
Fukui M.
Yasumoto T.
J.
Am. Chem. Soc.
1989,
111:
8929
2e
Murata M.
Legrand A.-M.
Ishibashi Y.
Fukui M.
Yasumoto T.
J.
Am. Chem. Soc.
1990,
112:
4380
2f
Satake M.
Morohashi A.
Oguri H.
Oishi T.
Hirama M.
Harada N.
Yasumoto T.
J. Am.
Chem. Soc.
1997,
119:
11325
2g For reviews of ciguatoxin
and related marine toxins, see: Yasumoto T.
Murata M.
Chem. Rev.
1993,
93:
1897
2h See also: Scheuer PJ.
Tetrahedron
1994,
50:
3
2i For a review of ciguatera,
see: Lewis RL.
Toxicon
2001,
39:
97
For the bioactivities of ciguatoxin
and related compounds, see:
3a
Bidard J.-N.
Vijverberg HPM.
Frelin C.
Chungue E.
Legrand A.-M.
Bagnis R.
Lazdanski M.
J. Biol. Chem.
1984,
259:
8353
3b
Lombet A.
Bidard JN.
Lazdanski M.
FEBS
Lett.
1987,
219:
355
3c For a review, see: Dechraoui M.-Y.
Naar J.
Pauillac S.
Legrand A.-M.
Toxicon
1999,
37:
125 ; see also the references cited in ref. 11
4 For the total synthesis of CTX3C,
a congener of ciguatoxin, see: Hirama M.
Oishi T.
Uehara H.
Inoue M.
Maruyama M.
Oguri H.
Satake M.
Science
2001,
294:
1904
For the recent synthetic studies
of ciguatoxins, see:
5a
Takakura H.
Sasaki M.
Honda S.
Tachibana K.
Org. Lett.
2002,
4:
2771
5b
Uehara H.
Oishi T.
Inoue M.
Shoji M.
Nagumo Y.
Kosaka M.
Brazidec J.-YL.
Hirama M.
Tetrahedron
2002,
58:
6493
5c
Sasaki M.
Noguchi T.
Tachibana K.
J.
Org. Chem.
2002,
67:
3301
5d
Takai S.
Isobe M.
Org. Lett.
2002,
4:
1183
5e
Bond S.
Perlmutter P.
Tetrahedron
2002,
58:
1779
5f
Maruyama M.
Inoue M.
Oishi T.
Oguri H.
Ogasawara Y.
Shindo Y.
Hirama M.
Tetrahedron
2002,
58:
1835
5g
Kira K.
Hamajima A.
Isobe M.
Tetrahedron
2002,
58:
1875
5h
Sasaki M.
Ishikawa M.
Fuwa H.
Tachibana K.
Tetrahedron
2002,
58:
1889
5i
Candenas ML.
Pinto FM.
Cintado CG.
Morales EQ.
Brouard I.
Díaz MT.
Rico M.
Rodríguez E.
Rodríguez RM.
Pérez R.
Pérez RL.
Martín JD.
Tetrahedron
2002,
58:
1921
5j
Takakura H.
Noguchi K.
Sasaki M.
Tachibana K.
Angew. Chem. Int. Ed.
2001,
40:
1090
5k
Oishi T.
Tanaka S.-i.
Ogasawara Y.
Maeda K.
Oguri H.
Hirama M.
Synlett
2001,
952
5l
Imai H.
Uehara H.
Inoue M.
Oguri H.
Oishi T.
Hirama M.
Tetrahedron
Lett.
2001,
42:
6219
5m
Kira K.
Isobe M.
Tetrahedron Lett.
2001,
42:
2821
5n
Saeeng R.
Isobe M.
Heterocycles
2001,
54:
789
5o
Oguri H.
Tanaka S.
Oishi T.
Hirama M.
Tetrahedron Lett.
2000,
41:
975
5p
Sasaki M.
Noguchi K.
Fuwa H.
Tachibana K.
Tetrahedron Lett.
2000,
41:
1425
5q
Kira K.
Isobe M.
Tetrahedron Lett.
2000,
41:
5951
5r
Liu T.-Z.
Isobe M.
Tetrahedron
2000,
56:
5391
5s
Liu T.-Z.
Isobe M.
Tetrahedron
2000,
56:
10209
For the convergent approaches, see:
6a
Nicolaou KC.
Angew. Chem., Int. Ed. Engl.
1996,
35:
589 ; and the references cited therein
6b
Alvarez E.
Díaz MT.
Hanxing L.
Martín JD.
J. Am. Chem.
Soc.
1995,
117:
1437
6c
Alvarez E.
Pérez R.
Rico M.
Rodríguez RM.
Martín JD.
J. Org. Chem.
1996,
61:
3003
6d
Ravelo JL.
Regueiro A.
Rodríguez E.
de Vera J.
Martín JD.
Tetrahedron Lett.
1996,
37:
2869
6e
Oishi T.
Nagumo Y.
Hirama M.
Synlett
1997,
980
6f
Oishi T.
Nagumo Y.
Hirama M.
Chem.
Commun.
1998,
1041
6g
Sasaki M.
Fuwa H.
Inoue M.
Tachibana K.
Tetrahedron Lett.
1998,
39:
9027
6h
Sasaki M.
Fuwa H.
Ishikawa M.
Tachibana K.
Org. Lett.
1999,
1:
1075
6i
Inoue M.
Sasaki M.
Tachibana K.
Tetrahedron
1999,
55:
10949
6j
Fujiwara K.
Morishita H.
Saka K.
Murai A.
Tetrahedron Lett.
2000,
41:
507
6k
Matsuo G.
Hinou H.
Koshino H.
Suenaga T.
Nakata T.
Tetrahedron
Lett.
2000,
41:
903
6l
Mori Y.
Mitsuoka S.
Furukawa H.
Tetrahedron
Lett.
2000,
41:
4161
6m
Díaz MT.
Pérez RL.
Rodríguez L.
Ravelo JL.
Martín JD.
Synlett
2001,
345
6n
Kadota I.
Ohno A.
Matsuda K.
Yamamoto Y.
J. Am. Chem. Soc.
2002,
124:
3562
For the synthetic studies of ciguatoxin
in this laboratory, see:
7a
Oka T.
Murai A.
Chem. Lett.
1994,
1611
7b
Oka T.
Fujiwara K.
Murai A.
Tetrahedron
1996,
52:
12091
7c
Atsuta H.
Fujiwara K.
Murai A.
Synlett
1997,
307
7d
Oka T.
Fujiwara K.
Murai A.
Tetrahedron
Lett.
1997,
38:
8053
7e
Oka T.
Murai A.
Tetrahedron
1998,
54:
1
7f
Oka T.
Fujiwara K.
Murai A.
Tetrahedron
1998,
54:
21
7g
Fujiwara K.
Saka K.
Takaoka D.
Murai A.
Synlett
1999,
1037
7h
Fujiwara K.
Tanaka H.
Murai A.
Chem.
Lett.
2000,
610
7i
Fujiwara K.
Takaoka D.
Kusumi K.
Kawai K.
Murai A.
Synlett
2001,
691
7j
Fujiwara K.
Koyama Y.
Doi E.
Shimawaki K.
Ohtaniuchi Y.
Takemura A.
Souma S.
Murai A.
Synlett
2002,
1496
8a
Ogura K.
Tsuchihashi G.
Tetrahedron
Lett.
1972,
2681
8b
Herrmann JL.
Richman JE.
Wepplo PJ.
Schlessinger RH.
Tetrahedron
Lett.
1973,
4707
9
Ishiyama T.
Murata M.
Miyaura N.
J.
Org. Chem.
1995,
60:
7508
10
Corey EJ.
Fuchs PL.
Tetrahedron Lett.
1972,
3769
11
Nicolaou KC.
Hwang C.-K.
Nugiel DA.
J.
Am. Chem. Soc.
1989,
111:
4136
12 When CH2Cl2 was
used as the solvent for the cyclization, the yield of 29 was reduced (35%) and many
unidentified byproducts were formed.
13 Stereochemistries at C9 and C10 of 29 were confirmed by the presence of NOE
(H9/H14) and the absence of NOE (H9/H10) as well
as the large value of 3
J
H9-H10 (7.5
Hz). The stereochemistries at C9 and C10 of 30 were
determined by the absence of NOEs (H9/H14 and H9/H10)
and the large value of 3
J
H9-H10 (8.0
Hz). So far, the isomerization at C9 in the ketone resulting from
oxidation of 30 into the desired stereochemistry
has not been successful. The isomerization at C9 and improvement
of the selectivity during the reductive cyclization of 4 are under investigation.
14 Compound 31 would
be produced by the addition of CH3CN to the intermediate
cyclic oxonium ion generated from 4 with
TMSOTf during the course of the reaction.
15 Representative data for 2: Colorless needles; mp 118-119 °C; [α]D
24 -13.6
(c 0.02, CHCl3); 1H
NMR (600 MHz, CD3CN, CHD2CN as 1.93 ppm): δ = 7.39-7.25
(30 H, m, Ph), 5.81 (1 H, dt, J = 13.2,
2.5 Hz, H15), 5.67 (1 H, brd, J = 13.2
Hz, H12), 5.64 (1 H, br d, J = 13.2
Hz, H11), 5.60 (1 H, dt, J = 13.2,
2.5 Hz, H16), 4.91 (1 H, d, J = 11.0
Hz, Bn), 4.85 (1 H, d, J = 11.0
Hz, Bn), 4.75 (1 H, d, J = 11.0
Hz, Bn), 4.61 (1 H, d, J = 11.4
Hz, Bn), 4.59 (1 H, d, J = 11.0
Hz, Bn), 4.53 (1 H, d, J = 12.1
Hz, Bn), 4.49 (1 H, d, J = 12.1
Hz, Bn), 4.47 (1 H, d, J = 12.1
Hz, Bn), 4.43 (1 H, d, J = 11.4
Hz, Bn), 4.40 (1 H, d, J = 12.1
Hz, Bn), 4.18 (1 H, br d, J = 9.2 Hz,
H13), 4.06 (1 H, dq, J = 8.2,
2.1 Hz, H17), 4.03 (1 H, dq, J = 9.2,
2.1 Hz, H14), 3.81 (1 H, br d, J = 9.2
Hz, H10), 3.70 (1 H, ddd, J = 8.2,
5.9, 2.8 Hz, H18), 3.64 (1 H, dd, J = 11.0, 2.8
Hz, H19a), 3.56-3.51 (4 H, m, H1, H5, H19b), 3.39 (1 H, td, J = 9.2, 6.6
Hz, H3), 3.35 (1 H, ddd, J = 11.4,
9.2, 4.8 Hz, H9), 3.21 (1 H, t, J = 9.2
Hz, H4), 3.05-3.15 (2 H, m, H6, H7), 2.20 (1 H, m, H8a),
2.02 (1 H, m, H2a), 1.56 (1 H, m, H2b), 1.41 (1 H, q, J = 11.4 Hz,
H8b); 13C NMR (100 MHz, CD3CN,
CD3
13CN as 118.2 ppm): δ = 140.1
(C in Ph), 139.8 (C in Ph), 139.60 (C in Ph), 139.56 (C in Ph),
139.2 (C in Ph), 134.3 (C12), 133.4 (C16), 131.6 (C11), 130.8 (C15), 128.2-129.2
(CH in Ph × 25), 84.49 (C5), 84.46 (C18), 83.8 (C14), 83.7
(C13), 82.7 (C6), 82.5 (C4), 80.8 (C10), 79.8 (C9), 77.4 (C17),
76.8 (C3), 75.6 (Bn), 75.1 (Bn), 73.9 (C7), 73.6 (Bn), 73.0 (Bn),
71.9 (Bn), 71.7 (C19), 66.7 (C1), 37.4 (C8), 32.9 (C2); IR(film): νmax = 3091,
3062, 3030, 2954, 2925, 2854, 1453, 1092, 738, 695 cm-1;
HR-FDMS: calcd for C54H59O9 [M + H]+:
851.4159. Found: 851.4182.